China Resources Pharmaceutical (03320) Announces Monthly Return for February 2026
Bulletin Express
Yesterday
China Resources Pharmaceutical Group Limited (stock code: 03320) reported that, as of 28 February 2026, its total issued ordinary shares remained at 6,282.51 million. No treasury shares were in issue, and there was no change in either the total share count or treasury shares during the month.
The company confirmed compliance with the applicable public float requirement set at 25.00%. Under its share option scheme, 628.45 million shares remained issuable or transferable out of treasury as of the end of February 2026. No new shares were issued, and no convertible securities or warrants were outstanding. This monthly return was submitted to Hong Kong Exchanges and Clearing Limited on 2 March 2026.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.